Amphastar Pharmaceuticals, Inc. Shares Outstanding (Cover Page)
Amphastar Pharmaceuticals, Inc. (AMPH) had Shares Outstanding (Cover Page) of 42.54 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 42.54M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 44.09M shares.
- 2026-02-20: Entity Common Stock, Shares Outstanding 45.37M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 45.95M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 42.54M shares 10-Q · filed 2026-08-06 |
| 2026-05-01 | 44.09M shares 10-Q · filed 2026-05-07 |
| 2026-02-20 | 45.37M shares 10-K · filed 2026-02-26 |
| 2025-10-31 | 45.95M shares 10-Q · filed 2025-11-06 |
| 2025-08-01 | 46.50M shares 10-Q · filed 2025-08-07 |
| 2025-05-01 | 47.14M shares 10-Q · filed 2025-05-08 |
| 2025-02-25 | 47.65M shares 10-K · filed 2025-03-03 |
| 2024-11-01 | 48.08M shares 10-Q · filed 2024-11-07 |
| 2024-08-02 | 48.68M shares 10-Q · filed 2024-08-09 |
| 2024-05-03 | 48.90M shares 10-Q · filed 2024-05-10 |
| 2024-02-22 | 48.10M shares 10-K · filed 2024-02-29 |
| 2023-11-02 | 47.91M shares 10-Q · filed 2023-11-08 |
| 2023-08-02 | 48.86M shares 10-Q · filed 2023-08-09 |
| 2023-05-03 | 48.27M shares 10-Q · filed 2023-05-09 |
| 2023-02-22 | 47.90M shares 10-K · filed 2023-03-01 |
| 2022-11-01 | 48.33M shares 10-Q · filed 2022-11-08 |
| 2022-08-02 | 49.02M shares 10-Q · filed 2022-08-09 |
| 2022-05-03 | 48.83M shares 10-Q · filed 2022-05-10 |
| 2022-03-04 | 48.15M shares 10-K · filed 2022-03-11 |
| 2021-11-02 | 47.85M shares 10-Q · filed 2021-11-09 |
| 2021-08-02 | 48.03M shares 10-Q · filed 2021-08-09 |
| 2021-05-03 | 47.64M shares 10-Q · filed 2021-05-07 |
| 2021-03-08 | 47.43M shares 10-K · filed 2021-03-15 |
| 2020-11-02 | 47.50M shares 10-Q · filed 2020-11-06 |
| 2020-08-03 | 47.49M shares 10-Q · filed 2020-08-07 |
| 2020-05-06 | 46.20M shares 10-Q · filed 2020-05-11 |
| 2020-03-09 | 46.24M shares 10-K · filed 2020-03-16 |
| 2019-11-01 | 46.94M shares 10-Q · filed 2019-11-08 |
| 2019-08-02 | 47.23M shares 10-Q · filed 2019-08-09 |
| 2019-05-03 | 47.07M shares 10-Q · filed 2019-05-10 |
| 2019-03-08 | 46.79M shares 10-K · filed 2019-03-15 |
| 2018-11-02 | 46.10M shares 10-Q · filed 2018-11-09 |
| 2018-08-02 | 46.26M shares 10-Q · filed 2018-08-09 |
| 2018-05-03 | 46.61M shares 10-Q · filed 2018-05-10 |
| 2018-03-06 | 46.35M shares 10-K · filed 2018-03-14 |
| 2017-11-02 | 45.98M shares 10-Q · filed 2017-11-09 |
| 2017-08-02 | 46.20M shares 10-Q · filed 2017-08-09 |
| 2017-05-03 | 45.74M shares 10-Q · filed 2017-05-10 |
| 2017-03-08 | 45.91M shares 10-K · filed 2017-03-15 |
| 2016-11-02 | 46.02M shares 10-Q · filed 2016-11-09 |
| 2016-08-02 | 45.12M shares 10-Q · filed 2016-08-09 |
| 2016-05-03 | 44.85M shares 10-Q · filed 2016-05-10 |
| 2016-03-08 | 44.91M shares 10-K · filed 2016-03-15 |
| 2015-11-09 | 45.02M shares 10-Q · filed 2015-11-13 |
| 2015-08-10 | 45.34M shares 10-Q · filed 2015-08-13 |
| 2015-05-11 | 44.72M shares 10-Q · filed 2015-05-14 |
| 2015-03-18 | 44.56M shares 10-K · filed 2015-03-26 |
| 2014-11-10 | 44.65M shares 10-Q · filed 2014-11-13 |
| 2014-08-08 | 44.64M shares 10-Q · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |